Issue 34 - The Cancer Letter

<img class="lazy" src="data:image/svg+xml,%3Csvg%20xmlns='http://www.w3.org/2000/svg'%20viewBox='0%200%201%201'%3E%3C/svg%3E" data-src="https://cdn.cancerletter.com/media/2021/03/17053004/TCL-logo-horizontal-white.png" alt="" >

Vol.

20

No.

34

September 09, 1994Sep 09, 1994

Free

DOWNLOAD THE PDF

Interim NSABP Leaders Will Not Nominate Chairman, Citing Exec. Committee “Bias”

In Brief: FDA approves Three-Hour Taxol Infusion; Foti Elected President Of NCCR; Luce Retires

PCI Files Application For Research Base COP

Eight applications Received For NSABP chairman

Pitt Criticizes NCI Stance On Repayment For Fraud Trials

Broder, Herberman, Decline To Coauthor Reanalysis of Data

“I Can’t Permit Destruction of NSABP,” Fisher Writes

Herberman: Progress Made To Stabilize NSABP

Recent Issues

Volume 52 | Issue 15 - April 17, 2026

Volume 52 | Issue 14 - April 10, 2026

Volume 52 | Issue 13 - April 03, 2026

Volume 52 | Issue 12 - March 27, 2026

Volume 52 | Issue 11 - March 20, 2026

Volume 52 | Issue 10 - March 13, 2026